You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三連板三聖股份(002742.SZ):子公司K13產品佔收入總體比重不高
格隆匯 02-07 19:54

格隆匯2月7日丨三聖股份(002742.SZ)公佈,公司股票日收盤價格漲跌幅偏離值累計異常,2020年2月5日、2020年2月6日、2020年2月7日連續三個交易日漲停。

近期,新型冠狀病毒(2019-nCoV)感染的肺炎疫情引起了廣泛關注。公司關注到Gilead Sciences,Inc.(吉利德科學)近期聲明提供在研藥物用於新型冠狀病毒(2019-nCoV)試驗性治療。經核實,公司與吉利德科學無直接業務關係;近期媒體報道,最新研究顯示體外細胞實驗中,達蘆那韋可對新型冠狀病毒(2019-nCoV)產生抑制作用,公司之子公司春瑞醫化從事醫藥中間體生產,其中K13產品是達蘆那韋的中間體,為春瑞醫化十多個中間體產品之一,其所佔收入總體比重不高。

公司注意到,上述針對新型冠狀病毒(2019-nCoV)的藥物尚處於驗證階段,對於醫藥中間體原料市場的影響存在重大不確定性。根據公司掌握的業務信息,上述事項不會對公司2020年度業績產生重大影響,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account